史赛克Stryker Corporation (SYK) 2003年年度报告「NYSE」.pdf

1、2003 Annual Report78777679 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00501001502002501.91.51.12.53.13.94.85.97.18.610.212.715.919.223.633.1 60.047.760.272.487.0104.5125.319.4221.0267.001 02 03345.6453.5300350400450NET EARNINGS*($millions)27-Year Compound Annual Growth Rate of 25%*B

2、efore 1990 extraordinary gain;1998 and 1999 reflectHowmedica acquisition-related costs and charges.CONTENTS02Letter to Shareholders062003 in Review 29 Financial ReviewORTHOPAEDIC IMPLANTSReconstructive ImplantsStryker OrthopaedicsOrthopaedic reconstructive productsincluding hip,knee and shoulderimpl

3、ants and bone cement.Production facilities in New Jersey,Ireland and France.Note:this division was previouslynamed Stryker HowmedicaOsteonics.Spinal SystemsStryker SpineSpinal implant products includingcervical,thoracolumbar and interbody systems used in spineinjury,deformity and degenerativetherapi

4、es.Global development centers in New Jersey and France;production facilities in France.Trauma and Micro ImplantsStryker TraumaTrauma-related products includingnailing,plating,hip fracture andexternal fixation systems.Productionfacilities in Germany andSwitzerland.Stryker Leibinger Micro ImplantsMicr

5、o plating systems and relatedproducts for craniomaxillofacial and hand surgery.Production facilities in Germany.OrthobiologicsStryker BiotechOsteogenic protein-1(OP-1)bonegrowth factor.Production facilities inMassachusetts,New Hampshire and Ireland.Stryker Corporation is a leader in the worldwide or

6、thopaedic market and is one of the worlds largestmedical device companies.Stryker delivers results through a wide range of capabilities including jointreplacements,trauma,spine and micro implant systems,orthobiologics,powered surgical instruments,surgical navigation systems and endoscopic products a